
Brian J. Gangle
Examiner (ID: 511, Phone: (571)272-1181 , Office: P/1645 )
| Most Active Art Unit | 1645 |
| Art Unit(s) | 1645 |
| Total Applications | 1233 |
| Issued Applications | 798 |
| Pending Applications | 132 |
| Abandoned Applications | 327 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 11276050
[patent_doc_number] => 09492522
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2016-11-15
[patent_title] => 'Compositions of vaccines and adjuvants and methods for the treatment of urinary tract infections'
[patent_app_type] => utility
[patent_app_number] => 14/842651
[patent_app_country] => US
[patent_app_date] => 2015-09-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 8
[patent_no_of_words] => 21967
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 16
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14842651
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/842651 | Compositions of vaccines and adjuvants and methods for the treatment of urinary tract infections | Aug 31, 2015 | Issued |
Array
(
[id] => 11948270
[patent_doc_number] => 20170252421
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-09-07
[patent_title] => 'COMPOUNDS AGAINST RALSTONIA PICKETTII FOR USE IN THE TREATMENT OF INSULIN RESISTANCE, AND METHOD OF DIAGNOSIS OF INSULIN RESISTANCE'
[patent_app_type] => utility
[patent_app_number] => 15/506948
[patent_app_country] => US
[patent_app_date] => 2015-08-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 9
[patent_figures_cnt] => 9
[patent_no_of_words] => 16113
[patent_no_of_claims] => 24
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15506948
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/506948 | COMPOUNDS AGAINST RALSTONIA PICKETTII FOR USE IN THE TREATMENT OF INSULIN RESISTANCE, AND METHOD OF DIAGNOSIS OF INSULIN RESISTANCE | Aug 27, 2015 | Abandoned |
Array
(
[id] => 11684088
[patent_doc_number] => 09682120
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2017-06-20
[patent_title] => 'Compositions and methods for the treatment of disorders involving epithelial cell apoptosis'
[patent_app_type] => utility
[patent_app_number] => 14/833611
[patent_app_country] => US
[patent_app_date] => 2015-08-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 10
[patent_figures_cnt] => 10
[patent_no_of_words] => 27591
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 90
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14833611
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/833611 | Compositions and methods for the treatment of disorders involving epithelial cell apoptosis | Aug 23, 2015 | Issued |
Array
(
[id] => 11520536
[patent_doc_number] => 09603917
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2017-03-28
[patent_title] => 'Immunologically active compositions'
[patent_app_type] => utility
[patent_app_number] => 14/833454
[patent_app_country] => US
[patent_app_date] => 2015-08-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 6
[patent_no_of_words] => 19372
[patent_no_of_claims] => 17
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 55
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14833454
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/833454 | Immunologically active compositions | Aug 23, 2015 | Issued |
Array
(
[id] => 11949499
[patent_doc_number] => 20170253650
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-09-07
[patent_title] => 'ANTI-PARASITIC COMPLEXES'
[patent_app_type] => utility
[patent_app_number] => 15/507173
[patent_app_country] => US
[patent_app_date] => 2015-08-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 11
[patent_figures_cnt] => 11
[patent_no_of_words] => 12668
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15507173
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/507173 | Anti-parasitic complexes | Aug 20, 2015 | Issued |
Array
(
[id] => 11943304
[patent_doc_number] => 20170247455
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-08-31
[patent_title] => 'TREATMENT OF CANCER USING A COMBINATION OF AN ANTI-PD-1 ANTIBODY AND AN ANTI-CD137 ANTIBODY'
[patent_app_type] => utility
[patent_app_number] => 15/505299
[patent_app_country] => US
[patent_app_date] => 2015-08-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 20
[patent_figures_cnt] => 20
[patent_no_of_words] => 23309
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15505299
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/505299 | TREATMENT OF CANCER USING A COMBINATION OF AN ANTI-PD-1 ANTIBODY AND AN ANTI-CD137 ANTIBODY | Aug 20, 2015 | Abandoned |
Array
(
[id] => 11901075
[patent_doc_number] => 09770495
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2017-09-26
[patent_title] => 'Immunogenic antigens from Aspergillus fumigatus'
[patent_app_type] => utility
[patent_app_number] => 14/824957
[patent_app_country] => US
[patent_app_date] => 2015-08-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 10
[patent_figures_cnt] => 17
[patent_no_of_words] => 12978
[patent_no_of_claims] => 6
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 141
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14824957
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/824957 | Immunogenic antigens from Aspergillus fumigatus | Aug 11, 2015 | Issued |
Array
(
[id] => 11851725
[patent_doc_number] => 20170226217
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-08-10
[patent_title] => 'COMBINATION THERAPIES WITH ANTI CD40 ANTIBODIES'
[patent_app_type] => utility
[patent_app_number] => 15/329402
[patent_app_country] => US
[patent_app_date] => 2015-08-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 13
[patent_figures_cnt] => 13
[patent_no_of_words] => 22969
[patent_no_of_claims] => 43
[patent_no_of_ind_claims] => 25
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15329402
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/329402 | Combination therapies with anti CD40 antibodies | Aug 11, 2015 | Issued |
Array
(
[id] => 10693741
[patent_doc_number] => 20160039888
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2016-02-11
[patent_title] => 'IMMUNOGENIC COMPOSITION COMPRISING ALPHA-HEMOLYSIN OLIGOPEPTIDES'
[patent_app_type] => utility
[patent_app_number] => 14/818817
[patent_app_country] => US
[patent_app_date] => 2015-08-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 27
[patent_figures_cnt] => 27
[patent_no_of_words] => 21519
[patent_no_of_claims] => 25
[patent_no_of_ind_claims] => 7
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14818817
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/818817 | IMMUNOGENIC COMPOSITION COMPRISING ALPHA-HEMOLYSIN OLIGOPEPTIDES | Aug 4, 2015 | Abandoned |
Array
(
[id] => 11757315
[patent_doc_number] => 20170204184
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-07-20
[patent_title] => 'ANTI-PD-L1 ANTIBODIES'
[patent_app_type] => utility
[patent_app_number] => 15/328232
[patent_app_country] => US
[patent_app_date] => 2015-08-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 19
[patent_figures_cnt] => 19
[patent_no_of_words] => 21991
[patent_no_of_claims] => 46
[patent_no_of_ind_claims] => 14
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15328232
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/328232 | Anti-PD-L1 antibodies | Aug 4, 2015 | Issued |
Array
(
[id] => 10438519
[patent_doc_number] => 20150323531
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2015-11-12
[patent_title] => 'Compositions and Methods for Detection of Antibodies Specific for Anaplasma phagocytophilum (Aph) and Anaplasma platys (Apl)'
[patent_app_type] => utility
[patent_app_number] => 14/813200
[patent_app_country] => US
[patent_app_date] => 2015-07-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 15799
[patent_no_of_claims] => 23
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14813200
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/813200 | Compositions and Methods for Detection of Antibodies Specific for Anaplasma phagocytophilum (Aph) and Anaplasma platys (Apl) | Jul 29, 2015 | Abandoned |
Array
(
[id] => 14913679
[patent_doc_number] => 10428146
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2019-10-01
[patent_title] => Anti PD-1 antibodies
[patent_app_type] => utility
[patent_app_number] => 15/328225
[patent_app_country] => US
[patent_app_date] => 2015-07-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 20
[patent_figures_cnt] => 20
[patent_no_of_words] => 21428
[patent_no_of_claims] => 26
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 199
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15328225
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/328225 | Anti PD-1 antibodies | Jul 21, 2015 | Issued |
Array
(
[id] => 11863944
[patent_doc_number] => 20170231230
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-08-17
[patent_title] => 'Novel Bacterium of Bacillus Genus and Uses Thereof'
[patent_app_type] => utility
[patent_app_number] => 15/503941
[patent_app_country] => US
[patent_app_date] => 2015-07-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 18
[patent_figures_cnt] => 18
[patent_no_of_words] => 15655
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15503941
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/503941 | Bacterium of | Jul 20, 2015 | Issued |
Array
(
[id] => 11668520
[patent_doc_number] => 20170157240
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-06-08
[patent_title] => 'COMPOSITION OF ALLERGEN EXTRACTS HAVING REDUCED TOXICITY AND METHOD OF PRODUCTION THEREOF'
[patent_app_type] => utility
[patent_app_number] => 15/325174
[patent_app_country] => US
[patent_app_date] => 2015-07-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 17
[patent_figures_cnt] => 17
[patent_no_of_words] => 15282
[patent_no_of_claims] => 24
[patent_no_of_ind_claims] => 13
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15325174
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/325174 | COMPOSITION OF ALLERGEN EXTRACTS HAVING REDUCED TOXICITY AND METHOD OF PRODUCTION THEREOF | Jul 15, 2015 | Abandoned |
Array
(
[id] => 12044560
[patent_doc_number] => 09822153
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2017-11-21
[patent_title] => 'Lentiviral vector based immunological compounds against malaria'
[patent_app_type] => utility
[patent_app_number] => 14/799633
[patent_app_country] => US
[patent_app_date] => 2015-07-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 15
[patent_figures_cnt] => 18
[patent_no_of_words] => 19610
[patent_no_of_claims] => 17
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 61
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14799633
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/799633 | Lentiviral vector based immunological compounds against malaria | Jul 14, 2015 | Issued |
Array
(
[id] => 11183711
[patent_doc_number] => 09415097
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2016-08-16
[patent_title] => 'Compositions of vaccines and adjuvants and methods for the treatment of urinary tract infections'
[patent_app_type] => utility
[patent_app_number] => 14/800003
[patent_app_country] => US
[patent_app_date] => 2015-07-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 10
[patent_no_of_words] => 22120
[patent_no_of_claims] => 30
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 9
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14800003
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/800003 | Compositions of vaccines and adjuvants and methods for the treatment of urinary tract infections | Jul 14, 2015 | Issued |
Array
(
[id] => 10715689
[patent_doc_number] => 20160061837
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2016-03-03
[patent_title] => 'ANTIBODY TO CYTOLETHAL DISTENDING TOXIN OF CAMPYLOBACTER JEJUNI'
[patent_app_type] => utility
[patent_app_number] => 14/793523
[patent_app_country] => US
[patent_app_date] => 2015-07-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 11606
[patent_no_of_claims] => 23
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14793523
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/793523 | Antibody to cytolethal distending toxin of Campylobacter jejuni | Jul 6, 2015 | Issued |
Array
(
[id] => 10422586
[patent_doc_number] => 20150307598
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2015-10-29
[patent_title] => 'YERSINIA SPP. POLYPEPTIDES AND METHODS OF USE'
[patent_app_type] => utility
[patent_app_number] => 14/793494
[patent_app_country] => US
[patent_app_date] => 2015-07-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 10
[patent_figures_cnt] => 10
[patent_no_of_words] => 25353
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14793494
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/793494 | Yersinia spp. polypeptides and methods of use | Jul 6, 2015 | Issued |
Array
(
[id] => 13165695
[patent_doc_number] => 10098940
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2018-10-16
[patent_title] => Exotoxin/thermolysin compositions and methods and uses for treating or preventing laminitis
[patent_app_type] => utility
[patent_app_number] => 15/320159
[patent_app_country] => US
[patent_app_date] => 2015-06-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6932
[patent_no_of_claims] => 6
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 53
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15320159
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/320159 | Exotoxin/thermolysin compositions and methods and uses for treating or preventing laminitis | Jun 18, 2015 | Issued |
Array
(
[id] => 11772481
[patent_doc_number] => 09381236
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2016-07-05
[patent_title] => 'Interferon-β production modulating listeria strains and methods for using same'
[patent_app_type] => utility
[patent_app_number] => 14/741107
[patent_app_country] => US
[patent_app_date] => 2015-06-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 20
[patent_figures_cnt] => 20
[patent_no_of_words] => 16858
[patent_no_of_claims] => 22
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 58
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14741107
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/741107 | Interferon-β production modulating listeria strains and methods for using same | Jun 15, 2015 | Issued |